John R Lau

This inventor holds 34 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Lipid-Based Drug Delivery. Top assignees: Sdg LLC, Technology Unlimited, Inc., Sdg Technology, Inc.. Active years: 1985-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John R Lau. Retrieved from https://idiyas.com/inventor/john-r-lau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 (Patent Applications = 9)

% Patents Active = 88.2

CIPO Patents = 5

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 11

Forward Citations = 1,126(Granted Patents)

Location History:

Wooster, OH (US) (1985 - 1992)
Howard, OH (US) (1995 - 2022)

Company Filing History:

Technology Unlimited, Inc.

4. 4 out of 834,513

Other

patents

Years Active: 1985-2022

Loading Chart...

Areas of Expertise:

Lipid Constructs

Insulin Delivery

Targeted Liposomes

Bioavailability

Hepatocyte Targeting

Therapeutics

Drug Delivery Systems

Vesicle Delivery

Chemical Activity Prolongation

Hair Care Agents

Organic Oil Stabilization

Diagnostic Uses

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11517529 - Orally bioavailable lipid-based constructs (2022-12-06),

2. 10751418 - Orally bioavailable lipid-based constructs (2020-08-25),

3. 10568835 - Orally bioavailable lipid-based constructs (2020-02-25),

4. 10463616 - Lipid construct for delivery of insulin to a mammal (2019-11-05),

5. 10004686 - Lipid construct for delivery of insulin to a mammal (2018-06-26),

6. 9943602 - Orally bioavailable lipid-based constructs (2018-04-17),

7. 9145453 - Orally bioavailable lipid-based constructs (2015-09-29),

8. 9034372 - Lipid construct for delivery of insulin to a mammal (2015-05-19),

9. 8962015 - Orally bioavailable lipid-based constructs (2015-02-24),

10. 8846053 - Orally bioavailable lipid-based constructs (2014-09-30),

11. 8303983 - Targeted liposomal drug delivery system (2012-11-06),

12. 8257735 - Method of increasing the bioavailability of recombinant human insulin isophane in a patient (2012-09-04),

13. 7871641 - Hepatocyte-targeting vehicle for delivery of glargine insulin to a mammal (2011-01-18),

14. 7858116 - Hepatocyte delivery vehicle for delivery of a combination of recombinant human regular insulin and recombinant human insulin isophane to a mammal (2010-12-28),

15. 7169410 - Targeted liposomal drug delivery system (2007-01-30),

Title: The Innovative Journey of John R Lau

Introduction: John R Lau, a distinguished inventor hailing from Howard, Ohio, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: John R Lau's latest patents showcase his continuous commitment to innovation and technological advancement in various industries.

Career Highlights: Throughout his illustrious career, John R Lau has demonstrated a remarkable ability to transform ideas into tangible inventions that have revolutionized the way we live and work. His innovative spirit and dedication to excellence have earned him a reputation as a visionary in the world of technology.

Collaborations: John R Lau has collaborated with leading companies, research institutions, and universities to further develop and commercialize his inventions. His partnerships have been instrumental in bringing his ideas to life and making a lasting impact on the industry.

Conclusion: John R Lau's passion for innovation, coupled with his relentless pursuit of excellence, has solidified his position as a pioneering inventor in the realm of technology. His contributions continue to inspire future generations of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.